258 related articles for article (PubMed ID: 31728485)
1. Biomimetic drug-delivery systems for the management of brain diseases.
Chen YX; Wei CX; Lyu YQ; Chen HZ; Jiang G; Gao XL
Biomater Sci; 2020 Feb; 8(4):1073-1088. PubMed ID: 31728485
[TBL] [Abstract][Full Text] [Related]
2. Multimodal and multiscale optical imaging of nanomedicine delivery across the blood-brain barrier upon sonopermeation.
May JN; Golombek SK; Baues M; Dasgupta A; Drude N; Rix A; Rommel D; von Stillfried S; Appold L; Pola R; Pechar M; van Bloois L; Storm G; Kuehne AJC; Gremse F; Theek B; Kiessling F; Lammers T
Theranostics; 2020; 10(4):1948-1959. PubMed ID: 32042346
[No Abstract] [Full Text] [Related]
3. Biomimetic Nanoparticle Drug Delivery Systems to Overcome Biological Barriers for Therapeutic Applications.
Fukuta T; Kogure K
Chem Pharm Bull (Tokyo); 2022; 70(5):334-340. PubMed ID: 35491189
[TBL] [Abstract][Full Text] [Related]
4. In vitro models and systems for evaluating the dynamics of drug delivery to the healthy and diseased brain.
Modarres HP; Janmaleki M; Novin M; Saliba J; El-Hajj F; RezayatiCharan M; Seyfoori A; Sadabadi H; Vandal M; Nguyen MD; Hasan A; Sanati-Nezhad A
J Control Release; 2018 Mar; 273():108-130. PubMed ID: 29378233
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of the brain-targeted delivery of drugs and model compounds using nano-delivery systems.
Kozlovskaya L; Stepensky D
J Control Release; 2013 Oct; 171(1):17-23. PubMed ID: 23831053
[TBL] [Abstract][Full Text] [Related]
6. Revolutionizing Neurocare: Biomimetic Nanodelivery Via Cell Membranes.
Liao J; Gong L; Xu Q; Wang J; Yang Y; Zhang S; Dong J; Lin K; Liang Z; Sun Y; Mu Y; Chen Z; Lu Y; Zhang Q; Lin Z
Adv Mater; 2024 Jun; 36(26):e2402445. PubMed ID: 38583077
[TBL] [Abstract][Full Text] [Related]
7. The Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to Brain.
Sharma G; Lakkadwala S; Modgil A; Singh J
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231900
[TBL] [Abstract][Full Text] [Related]
8. Innovations in Liposomal DDS Technology and Its Application for the Treatment of Various Diseases.
Oku N
Biol Pharm Bull; 2017; 40(2):119-127. PubMed ID: 28154249
[TBL] [Abstract][Full Text] [Related]
9. [Development of DDS Actively to Overcome the Blood-brain Barrier in the Region of Ischemic Stroke].
Fukuta T; Kogure K
Yakugaku Zasshi; 2020; 140(8):1007-1012. PubMed ID: 32741858
[TBL] [Abstract][Full Text] [Related]
10. From blood to brain: blood cell-based biomimetic drug delivery systems.
Li YJ; Wu JY; Liu J; Qiu X; Xu W; Tang T; Xiang DX
Drug Deliv; 2021 Dec; 28(1):1214-1225. PubMed ID: 34142628
[TBL] [Abstract][Full Text] [Related]
11. Delivery of a peptide-drug conjugate targeting the blood brain barrier improved the efficacy of paclitaxel against glioma.
Li Y; Zheng X; Gong M; Zhang J
Oncotarget; 2016 Nov; 7(48):79401-79407. PubMed ID: 27765902
[TBL] [Abstract][Full Text] [Related]
12. Glioma-targeted dual functionalized thermosensitive Ferri-liposomes for drug delivery through an in vitro blood-brain barrier.
Shi D; Mi G; Shen Y; Webster TJ
Nanoscale; 2019 Aug; 11(32):15057-15071. PubMed ID: 31369016
[TBL] [Abstract][Full Text] [Related]
13. Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system.
Crawford L; Rosch J; Putnam D
J Control Release; 2016 Oct; 240():251-266. PubMed ID: 26724368
[TBL] [Abstract][Full Text] [Related]
14. Blood-Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery via Albumin-Binding Protein Pathways for Antiglioma Therapy.
Lin T; Zhao P; Jiang Y; Tang Y; Jin H; Pan Z; He H; Yang VC; Huang Y
ACS Nano; 2016 Nov; 10(11):9999-10012. PubMed ID: 27934069
[TBL] [Abstract][Full Text] [Related]
15. [Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases].
Kanazawa T
Yakugaku Zasshi; 2018; 138(4):443-450. PubMed ID: 29607986
[TBL] [Abstract][Full Text] [Related]
16. Peptide-decorated nanocarriers penetrating the blood-brain barrier for imaging and therapy of brain diseases.
Gao X; Xu J; Yao T; Liu X; Zhang H; Zhan C
Adv Drug Deliv Rev; 2022 Aug; 187():114362. PubMed ID: 35654215
[TBL] [Abstract][Full Text] [Related]
17. Application and Utility of Liposomal Neuroprotective Agents and Biomimetic Nanoparticles for the Treatment of Ischemic Stroke.
Fukuta T; Oku N; Kogure K
Pharmaceutics; 2022 Feb; 14(2):. PubMed ID: 35214092
[TBL] [Abstract][Full Text] [Related]
18. From nose to brain: understanding transport capacity and transport rate of drugs.
Wu H; Hu K; Jiang X
Expert Opin Drug Deliv; 2008 Oct; 5(10):1159-68. PubMed ID: 18817519
[TBL] [Abstract][Full Text] [Related]
19. [Proceedings of new drug delivery systems and their applications in the traditional Chinese drugs].
Zhou SH; Xiao XH; Yuan HL; Zhao YL; Shan LM; Cai GM
Zhongguo Zhong Yao Za Zhi; 2003 Jul; 28(7):589-92. PubMed ID: 15139097
[TBL] [Abstract][Full Text] [Related]
20. Current advances in delivery of biotherapeutics across the blood-brain barrier.
Rajadhyaksha M; Boyden T; Liras J; El-Kattan A; Brodfuehrer J
Curr Drug Discov Technol; 2011 Jun; 8(2):87-101. PubMed ID: 21513485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
